Biotech | April 29, 2022
Once-weekly icodec demonstrates superior reduction in HbA1c vs degludec
In the trial, there was no statistical difference in estimated hypoglycaemia rates, and no severe hypoglycaemia events were observed for people treated with insulin icodec
